A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.

Saved in:
Bibliographic Details
Title: A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.
Authors: Cooper D; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK., Ansari MT; Independent Research Methodologist, Ottawa, ON, Canada., Aurelius T; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK., Bobbins A; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK., Dhanda S; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK., Gravel CA; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; Department of Mathematics and Statistics, University of Ottawa, Ottawa, ON, Canada.; Data Literacy Research Institute, University of Ottawa, Ottawa, ON, Canada., Hauben M; Merck KGaA, Darmstadt, Germany.; Department of Family and Community Medicine, New York Medical College, Valhalla, NY, USA., Morris D; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK., Morton K; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK., Platt R; School of Population and Global Health, McGill University, Montreal, QC, Canada., Van Puijenbroek E; Department of PharmacoTherapy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., Yeomans A; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK., Davies M; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK. Miranda.davies@dsru.org.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK. Miranda.davies@dsru.org.
Source: Drug safety [Drug Saf] 2026 Aug; Vol. 49 (8), pp. 883-897. Date of Electronic Publication: 2026 Mar 30.
Publication Type: Journal Article; Scoping Review; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41910704
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cooper+D%22">Cooper D</searchLink>; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK.<br /><searchLink fieldCode="AU" term="%22Ansari+MT%22">Ansari MT</searchLink>; Independent Research Methodologist, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Aurelius+T%22">Aurelius T</searchLink>; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK.<br /><searchLink fieldCode="AU" term="%22Bobbins+A%22">Bobbins A</searchLink>; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK.<br /><searchLink fieldCode="AU" term="%22Dhanda+S%22">Dhanda S</searchLink>; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK.<br /><searchLink fieldCode="AU" term="%22Gravel+CA%22">Gravel CA</searchLink>; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; Department of Mathematics and Statistics, University of Ottawa, Ottawa, ON, Canada.; Data Literacy Research Institute, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Hauben+M%22">Hauben M</searchLink>; Merck KGaA, Darmstadt, Germany.; Department of Family and Community Medicine, New York Medical College, Valhalla, NY, USA.<br /><searchLink fieldCode="AU" term="%22Morris+D%22">Morris D</searchLink>; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK.<br /><searchLink fieldCode="AU" term="%22Morton+K%22">Morton K</searchLink>; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK.<br /><searchLink fieldCode="AU" term="%22Platt+R%22">Platt R</searchLink>; School of Population and Global Health, McGill University, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Van+Puijenbroek+E%22">Van Puijenbroek E</searchLink>; Department of PharmacoTherapy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Yeomans+A%22">Yeomans A</searchLink>; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK.<br /><searchLink fieldCode="AU" term="%22Davies+M%22">Davies M</searchLink>; Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK. Miranda.davies@dsru.org.; School of Medicine, Pharmacy, and Biomedical Science, University of Portsmouth, Portsmouth, UK. Miranda.davies@dsru.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229002928%22">Drug safety</searchLink> [Drug Saf] 2026 Aug; Vol. 49 (8), pp. 883-897. <i>Date of Electronic Publication: </i>2026 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Scoping Review; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9002928 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201145916%22">01145916 </searchLink><i>NLM ISO Abbreviation: </i>Drug Saf <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41910704
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40264-026-01665-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 883
    Titles:
      – TitleFull: A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cooper D
      – PersonEntity:
          Name:
            NameFull: Ansari MT
      – PersonEntity:
          Name:
            NameFull: Aurelius T
      – PersonEntity:
          Name:
            NameFull: Bobbins A
      – PersonEntity:
          Name:
            NameFull: Dhanda S
      – PersonEntity:
          Name:
            NameFull: Gravel CA
      – PersonEntity:
          Name:
            NameFull: Hauben M
      – PersonEntity:
          Name:
            NameFull: Morris D
      – PersonEntity:
          Name:
            NameFull: Morton K
      – PersonEntity:
          Name:
            NameFull: Platt R
      – PersonEntity:
          Name:
            NameFull: Van Puijenbroek E
      – PersonEntity:
          Name:
            NameFull: Yeomans A
      – PersonEntity:
          Name:
            NameFull: Davies M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2026 Aug
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1942
          Numbering:
            – Type: volume
              Value: 49
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Drug safety
              Type: main
ResultId 1